MARKETS PERPS LIVE116

Cash

Trending Elections Politics Culture Sports Crypto Commodities Climate Economics Mentions Finance Tech & Science

Predict Live116 AccountSocial

Product

Kalshi Pro Perpetual Futures Markets Incentive program Institutions API & developers

Company

About Kalshi Research Blog Careers Policy Center Brand Kit

Help

Help Center FAQ Fee schedule Trading hours Regulatory Trust Center

© 2026 Kalshi Inc. · All rights reserved

Privacy Data Terms of Service Trading Prohibitions FAQ for Finance Professionals

Trading on Kalshi involves risk and may not be appropriate for all. Members risk losing their cost to enter any transaction, including fees. You should carefully consider whether trading on Kalshi is appropriate for you in light of your investment experience and financial resources. Any trading decisions you make are solely your responsibility and at your own risk. Information is provided for convenience only on an "AS IS" basis. Past performance is not necessarily indicative of future results. Kalshi is subject to U.S. regulatory oversight by the CFTC.

Johnson & Johnson (JNJ) earnings | Kalshi

Johnson & Johnson

JNJ

ReportsOct 13, 2026 · before open

Fiscal periodNot stated

Market cap$651.20B

Consensus EPS$2.96 · 6 estimates

Year-ago EPS$2.80

Expected change+5.7%

Quarterly markets

What will Johnson & Johnson say during their next earnings call?

Ottava
92%
Procedure
90%
Rybrevant
89%
China
88%
Tariff
82%
Litigation
74%
Halda Therapeutics
56%
AI / Artificial Intelligence
46%
Nipocalimab / Lupus
34%
Administration
31%
Gene Therapy
9%
Vaccine
6%